Evidence map›Paper›PMID 28193170›Full record

ArticleBMC medical research methodology2017

Generating evidence on a risk-based monitoring approach in the academic setting - lessons learned.

Belinda von Niederhäusern, Annette Orleth, Sabine Schädelin, Nawal Rawi, Martin Velkopolszky, Claudia Becherer, Pascal Benkert, Priya Satalkar, Matthias Briel, Christiane Pauli-Magnus

Abstract read
In one paragraph

Article in BMC medical research methodology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Monitoring strategies for clinical intervention studies.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Belinda von NiederhäusernClinical Trial Unit, Department of Clinical Research, University Hospital Basel, Basel, Switzerland. belinda.vonniederhausern@usb.ch.
Annette OrlethDepartment of Medicine, Biomedicine and Clinical Research, Neurology, University Hospital Basel, Basel, Switzerland.
Sabine SchädelinClinical Trial Unit, Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
Nawal RawiNovartis Pharma, Basel, Switzerland.
Martin VelkopolszkyClinical Trial Unit, Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
Claudia BechererClinical Trial Unit, Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
Pascal BenkertClinical Trial Unit, Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
Priya SatalkarInstitute for Biomedical Ethics, University of Basel, Basel, Switzerland.
Matthias BrielBasel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
Christiane Pauli-MagnusClinical Trial Unit, Department of Clinical Research, University Hospital Basel, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn spite of efforts to employ risk-based strategies to increase monitoring efficiency in the academic setting, empirical evidence on their effectiveness remains sparse. This mixed-methods study aimed to evaluate the risk-based on-site monitoring approach currently followed at our academic institution.

methodsWe selected all studies monitored by the Clinical Trial Unit (CTU) according to Risk ADApted MONitoring (ADAMON) at the University Hospital Basel, Switzerland, between 01.01.2012 and 31.12.2014. We extracted study characteristics and monitoring information from the CTU Enterprise Resource Management system and from monitoring reports of all selected studies. We summarized the data descriptively. Additionally, we conducted semi-structured interviews with the three current CTU monitors.

resultsDuring the observation period, a total of 214 monitoring visits were conducted in 43 studies resulting in 2961 documented monitoring findings. Our risk-based approach predominantly identified administrative (46.2%) and patient right findings (49.1%). We identified observational study design, high ADAMON risk category, industry sponsorship, the presence of an electronic database, experienced site staff, and inclusion of vulnerable study population to be factors associated with lower numbers of findings. The monitors understand the positive aspects of a risk-based approach but fear missing systematic errors due to the low frequency of visits.

conclusionsWe show that the factors mostly increasing the risk for on-site monitoring findings are underrepresented in the current risk analysis scheme. Our risk-based on-site approach should further be complemented by centralized data checks, allowing monitors to transform their role towards partners for overall trial quality, and success.

Indexed as

Epidemiological MonitoringObservational Studies as TopicPractice Guidelines as TopicQuality Assurance, Health CareResearch DesignHospitals, UniversityHumansRetrospective StudiesRisk AssessmentSurveys and QuestionnairesSwitzerlandAcademiaMonitoringOn-site monitoringQuality AssuranceRisk-basedRisk proportionate

Identifiers

PMID28193170
PMCPMC5307807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.